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Abstract: Enhancement of blood fibrinogen or factor VII increases cardiovascular diseases. Allium hirtifolium Boiss 
(Mosir) has been shown to have cardioprotective effect. This study, therefore, aimed to evaluate the effects of 
Allium hirtifolium Boiss on factor VII and fibrinogen blood levels. Its radical scavenging property was also 
measured. Twenty four NewZealand male rabbits were randomly designated into 3 groups of 8 and were fed for 60 
days with normal diet, hypercholestrol (1%) diet or hypercholestrol (1%) diet+ Mosir. At the beginning and 60 days 
after the start of the study, the blood fibrinogen and factor 7 were measured and compared in different groups. The 
Mosir radical scavenging property was measured using the beta-carotene linoleate method. The blood fibrinogen and 
factor 7 were higher in hypercholesterolemic group (26.7 ± 329.22 and 17.1 ± 277.7mg/dl) compared to normal diet 
group (13.7 ± 287.25 and 18.2 ± 230.0 mg / dl, respectively) (P<0.05), at the end of the experiment. The amount of 
blood fibrinogen and factor 7 were decreased in hypercholesterol+Mosir group (23.9 ± 180.00 and 53.3 ± 237.0 mg / 
dl) compared to hypercholesterol diet group (P<0.05). radical scavenging activity of Mosir extract was 52.1 ± 3.3%.  
Mosir may have beneficial effect on heart by decreasing blood fibrinogen and factor 7 as cardiovascular risk factors. 
These effects of Mosir should be considered carefully in patients with hemostatic disorders. 
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Introduction:  
Cardiovascular diseases, especially atherosclerosis, are 
growing rapidly and are considered the first cause of 
death in industrialized societies (1, 2). Studies done in 
America and Europe have estimated occurrence range 
of cardiovascular diseases at 3 to 8 percent. According 
to surveys conducted by the Ministry of Health and 
Medical Education, 5.38 percent of deaths in Iran occur 
due to coronary artery disease (1). Studies have shown 
that regulation of hemostatic and Thrombogenic factors 
potential by simple changes in lifestyle can be 
considered as primary or secondary prevention (3). 
Today, the factor VII and fibrinogen activity 
(Hemostatic factors) have been recognized as risk 
factors involved in cardiovascular diseases. Now, 
different procedures and medications including 
supplements of vitamins E, folic acid, B6 and B12 
vitamins, and if necessary, anticoagulant drugs are used 
for the control of these risk factors and prevention of 
vascular disease (4, 5). However despite the use of 
these supplements, it seems that outbreak of 
atherosclerosis, progression of acute coronary 
syndromes and brain ischemia or ischemia in other 
tissues can be still prevented by inhibiting the 
coagulation and inflammation activity. 
Factor VII is a vitamin K dependent factor that is 
produced by hepatocytes and is released in the blood 
stream. High plasma level of factor VII is associated 
with a risk increase in development of arterial 
thrombosis. 25 percent increase in factor VII activity 
increases risk of fatal coronary artery disease by 55 
percent (6). It also has been identified that factor VII 
levels is associated with serum triglyceride levels. 
Nutrition with a high fat diet caused increase in the 
lipoproteins and triglycerides concentration and 
lipolysis of large lipoprotein particles causes increase 
in activated factor VII (7). Factor VII activity levels in 
people who have a high fat diet is 16 percent more than 
those who consume low-fat diet (8). 
Fibrinogen is a protein with a high molecular weight 
produced by the liver and its normal average level is 
250mg/dl. Plasma fibrinogen levels increase in 
inflammatory, malignant and liver diseases (9). Plasma 
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fibrinogen increase could be prelude to clot formation 
increase (10). Although the increase in plasma 
fibrinogen associated with other risk factors for 
coronary artery disease such as age, smoking, high 
blood pressure, elevated blood fats, diabetes and 
obesity can be seen, but fibrinogen as an independent 
risk factor also plays a role in the development of 
atherosclerosis disease (11, 12). Fibrinogen by 
affecting on plasma viscosity fibrinogen, platelet 
aggregation and the fibrin level which it forms provides 
the risk of developing coronary artery disease (14, 15).  
Several studies have shown the relationship between 
plasma fibrinogen level and severity of coronary artery 
disease in the angiography. Most of these studies 
consider this matter mainly due to the obstruction of 
the vessel lumen which is a sign of this subject that 
plasma fibrinogen increase is a thrombogen factor (16). 
Reports show correlation between components of the 
clotting system (fibrinogen and factor VII) and 
fibrinolytic factors such as tissue plasminogen activator 
(TPA) and plasminogen activator inhibitor (PAI) and 
atherosclerosis (17).  
Studies show that flavonoids and phenolic compounds 
in plants have many biological effects including 
antioxidant properties, inhibition of free radicals and 
anti-inflammatory effects (18). According to increasing 
prevalence of heart disease and reduction in age of 
getting this disease, investigating for new drugs and 
herbs for control and prevention of atherosclerosis 
plaque and reduction in cardiovascular disease risk 
factors is important. Shallot (Allium hirtifolium Boiss) 
is a species of tulips large family consisting of about 
500 known different species. The family in addition to 
shallot includes other important species known as 
garlic, onions and leeks which have food and drug 
application throughout the world (20, 19). Allium 
plants use has been common as local traditional drug 
since ancient times and such plants have been used for 
centuries because of its medicinal value and properties. 
These plants are rich in flavonols and organosulfur 
compounds and have shown the anticancer properties 
in in vitro studies (21). Shallot is a traditional plant like 
garlic, but its chive is darker than garlic and is often 
used as a food flavoring in the diet. Heretofore, 
numerous studies have been conducted on the 
properties and characteristics of shallot which among 
them we can mention Hypocholesterolemia effects 
(22), having activity of inhibiting hemolysis and 
depletion of glutathione due to stress in human 
erythrocyte (23), hypoglycemia and  
hypercholesterolemia effects (24, 25), antibacterial  
effects (26), high antioxidant potential (27) and the 
Hematological effects (28). Moreover, some of 
effective compounds in this plant such as antifungal 
peptide askaline (29) and mannose-specific lectin (30) 
have been identified and isolated. The results showed 
that edible prescription of alcoholic extract of shallot 
for 20 days cause decrease in total cholesterol level and 
LDL and increase in HDL and prescription of this plant 
has no effect on serum triglycerides level (31). Also it 
has been proven that prescription of shallot extract in 
male rats could reduce lipid peroxidation due to having 
antioxidant (31). As for the existing compounds in 
shallots and its hypocholesterolemic effects and effect 
of blood hemostatic potential on atherosclerosis and 
cardiovascular diseases, if this plant causes decrease in 
hemostatic factors, it could be very helpful in 
cardiovascular diseases. Since the plant was proposed 
as a powerful antioxidant compound and some reports 
suggest its protective effect on cardiology system, 
therefore the aim of this study was to evaluate the 
shallot effect on fibrinogen and Factor VII in rabbits 
consuming high cholesterol. The Mosir radical 
scavenging property was also measured using the beta-
carotene linoleate method. 
 
Methodology 
Extraction 
In this experiment, the collected shallots from 
Koohrang area in Chaharmahal & Bakhtiari province 
was approved by Medicinal Plants Research Center of 
Shahrekord University of Medical Sciences and the 
extract obtained from it were used intraperitoneally in 
rabbits. During the period, body weight and food intake 
were measured.  
After drying shallot in the shade and crushing, act of 
the extraction was performed at temperature of 20 -15 
with 80 percent ethanol. For this purpose, the powder 
was soaked in solvent. 100 g of plant powder was 
poured in 500 ml of 80% ethanol. 48 hours later, after 
filtering the extract, extraction repeated twice and the 
collected plant extract was transferred to the vacuum 
distillation unit and concentrated. Then it was dried at a 
temperature of 40 ° C (32).  
 
Grouping and rabbits treatment 
In an interventional study, 24 New Zealand male 
rabbits weighing 9/12 ± 2010 g were purchased from 
Razi Institute, Karaj and were kept in animal kennel of 
Medicinal Plants Research Center, Shahrekord 
University of Medical Sciences for two weeks at an 
appropriate temperature and humidity, hours of natural 
darkness and light and standard basal diet and then 
were treated. Rabbit nourishment was done by standard 
prepared grain food purchased from Pars feed company 
(Tehran) which contains 15% protein, 40-50% 
carbohydrates, 2% vegetable fat and 15 to 25% fiber. 
In order to prepare food after scientific confirmation, 
the obtained powder after grinding cholesterol with 
weight ratio of 0.01 was mixed with the powdered and 
standard food and animal feed was produced again. 
During the experiment period the animals had access to 
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enough food and water. Rabbits were randomly divided 
into 3 groups of 8 as described below and were under 
the various regimes for 60 days as follows: Basal diet, 
high cholesterol diet (1%), high cholesterol diet (1%) + 
shallot extract (1g/kg BW) (32). Shallot extract was 
injected intraperitoneally once a day (about 11 am) for 
60 days.  
 
Biochemical factors measurement:  
Before the beginning and end of the study, the animals 
were fasted for 12 hours, and blood samples of rabbits 
were taken from the central ear artery. Blood taken 
from rabbits was poured in two separate tubes to 
prepare serum and plasma. Tubes with specific number 
and date were centrifuged for 20 minutes at 3500 rpm 
in order to prepare serum and plasma. Fibrinogen level 
was measured by Mahsayaran kit and factor VII was 
measured by STA-Deficient VII kit (15).  
 
Measurement of the antioxidant activity by beta-
carotene-linoleate method  
Beta-carotene-linoleate method was used for measuring 
antioxidant capacity (33). Two milligrams of beta-
carotene was solved in 2/0 ml of chloroform. 20 mg 
linoleic acid and 200 mg Tween 40 were added to the 
emulsion. 40 ml of water saturated with oxygen was 
added to the above materials. Shallot extract was 
prepared at a concentration of 2/0 milligrams per liter 
in pure ethanol. 4 ml of the prepared solution was 
added to 2 ml of the prepared extract and control 
(ethanol). Antioxidant activity of extract based on 
Beta-Carotene Bleaching rate at a wavelength of 470 
nm and at 180 minutes (15 minute intervals), and by 
using the following formula was calculated and the 
mean of obtained values was considered as the percent 
of antioxidant activity of the extract. 
Formula 1: 
  AA = 100 [1 - (Ao-At) / (Aoo - Aot)]  
Ao and Aoo represent the absorbance of light at time 
zero, At Aot represent the absorbance of light at 
different times during 180 minutes for the sample and 
control (33). 
Measurement of plasma antioxidant capacity: 
Plasma antioxidant capacity was measured by using 
Tripyridyl Triazine (TPTZ) (Sigma Co, USA) and 
based on dr Heydarian et al method. Reduction of ferric 
to ferrous ions in the presence of antioxidants creates 
colored ferrous tri-pyridyl-triazine complex which has 
maximum absorbance of light at 593 nm. FeSO4 in the 
range of 100 to 1000 mM was used in order to draw the 
standard curve. In this method, first a working solution 
was prepared with a ratio of 10:1:1 from 10 mM 
triazine in 40mM chloridric acid, 20 mM solution of 
FeCl3 (Merck, Germany) and 300 mM acetate buffer 
(buffer solution 10 volume, each of triazine and FeCl3 
1 volume). Then 25 μl of each sample’s plasma was 
poured in clean tubes and 1/5 ml of working solution 
was added to each tube (One test tube was prepared for 
blank that instead of sample, distilled water was added 
to it). The tubes were incubated for 10 minutes in water 
bath at 37°C and subsequently each sample’s 
absorbance of light relative to blank at a wavelength of 
593 nm was read (34).  
 
Statistical Analysis:  
Results were analyzed using Instat 3 software. To 
investigate the biochemical results and comparison of 
the experimental groups, Kruskal - Wallis and Dunn 
tests were used and P<0.05 was considered statistically 
significant.  
 
Results:  
The results of this study showed that at the beginning 
of the period, biochemical factors values among the 
study groups were not significantly different (P> 0.05). 
Comparison of blood’s fibrinogen level in the basal 
diet (normal) and high-cholesterol diet (1%) groups 
indicated that fibrinogen level in high-cholesterol 
group compared to basal diet group had significant 
increase (P<0.05). Also significant reduction was 
observed in high-cholesterol+shallot group compared 
to high-cholesterol diet (P<0.05) (Table 1). Factor VII 
level in high-cholesterol group had significant increase 
compared to basal diet (P<0.05) and significant 
decrease in high-cholesterol+shallot group compared to 
high-cholesterol diet was observed (P<0.05) (Table 1).  
 
 
 
 
Table 1: Mean (mg/dl) of fibrinogen and factor VII levels in the diet groups under study  
 diet Fibrinogen ± SD Factor VII ± SD 
1 Basal (normal) 7/13±25/287  2/18±0/230  
2 High-cholesterol (1%) 7/26±22/329 a 1/17±7/277 a 
3 High cholesterol (1%) + shallot 9/23±00/180 b 3/53±0/237 b 
a:P<0.05,compared with the basal diet group 
b:P<0.05,compared with high-cholesterol diet group 
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In this study, the antioxidant capacity of shallot extract 
with concentration of 0.2 g / L, equivalent to 52.1 ± 
3.3%, was obtained. The antioxidant capacity of 
plasma in shallots + high-cholesterol group was 
obtained 943.907 ± 249.51μM that was far more than 
the basal (normal) group, 629.675 ± 130.73μM. The 
results showed that there is a significant correlation 
between the antioxidant capacity of shallots + high-
cholesterol group (943.907 ± 249.51μM) and 
antioxidant capacity of samples before the intervention 
(440.089 ± 99.99μM) (P <0.001). 
 
 
 
Figure 1: Comparison of the antioxidant capacity of plasma samples in tested groups (μM) 
 
 
Discussion:  
The results of this study showed that groups treated 
with shallots had significant decrease in fibrinogen and 
factor VII levels compared to the high-cholesterol 
group. Disorders of fibrinogen and coagulation are 
related to the development of cardiovascular diseases 
such as coronary artery disease, hypertension and 
ischemic shock (34).  
Some vegetarian diets are effective in reducing 
concentration of clotting factors or increasing 
fibrinolysis and are involved in this process by 
reducing blood clotting with reducing fibrinogen, 
inhibition of platelet aggregation and increasing 
prothrombin time (35). The results have shown that 
edible prescription of alcoholic extract of shallot for 20 
days cause decrease in total cholesterol level and LDL 
and increase in HDL (25). HALL studies in 1996 
showed that there is a relationship between HDL and 
fibrinogen. People who have high HDL levels have low 
fibrinogen levels. The inhibitory effect of HDL on 
factor X activates proteins C and S (these proteins may 
inhibit coagulation factor V) that these factors reduce 
production of fibrinogen. HDL also inhibits platelet 
aggregation. Therefore, decrease in fibrinogen could 
also be due to an increase in HDL. Effect on reducing 
blood cholesterol is done by inhibiting production of  
HMG-CoA reductase. This enzyme causes conversion 
of hydroxymethyl glutaryl-CoA to mevalonic acid and 
its revival which is a one-way reaction and occurs in  
 
 
endoplasmic reticulum of cells (36). Studies have 
shown that garlic powder has anti-thrombotic effects 
due to having allicin, level of thrombin-
antithrombin(III) complex have been decreased to 
normal level (37). Allicin is the major factor for its 
beneficial effects against blood lipids, blood pressure 
and blood clotting (36). It’s recognized that long-term 
and edible use of shallot causes reduction of free 
radicals and protecting cells against chemical damage, 
reduction of lipid peroxidation and protecting liver 
against a variety of stresses that its main reason is its 
high level of antioxidants (38). Therefore, the use of 
the plant applies protective effects on body tissues and 
works toward reduction of oxidative stress (39). 
Flavonoids such as coarsetin, compferrol, myristin are 
inhibitors of platelet aggregation. Given that Shallot 
has several medicinal effects such as antioxidant 
property (39) make polyphenols rapidly absorbed and 
cause increase in the blood concentration to induce 
expression increase of mRNA and fibrinolytic proteins 
such as t-PA and setup reduction of PAI (40), which 
could partly explain the anti-inflammatory effects and 
improve blood lipid profiles and reduce lipid 
peroxidation in hypercholesterolemic individuals (8). 
Treatment with antioxidant factors such as Allium 
ampeloprasum with high doses of cysteine sulfoxide 
compounds can be effective in this regard (41). 
Furthermore it has been recognized that the antioxidant 
effect of this group of materials is applied by 
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increasing enzymes level related to dismutase and 
catalase antioxidant systems. On the other hand, this 
material is able to reduce the production of end 
products of lipid peroxidation such as malondialdehyde 
and hydroproxside (42). On the other hand, part of 
observed effects of the plant use in the present study 
should be attributed to the high percentage of 
anthocyanins with protective properties (41). Thus, by 
inhibition of coagulation and inflammatory activities of 
platelets, atherosclerosis and acute coronary syndromes 
and brain ischemia or ischemia in other tissues can be 
likely prevented.  
 
Conclusion: 
By considering the use of shallot in modern societies 
and according to its antioxidant effect and its certain 
role in the occurrence and development of various 
chronic diseases including cardiovascular disease, its 
preventive role in the incidence of these diseases is so 
important. In addition, according to researcher’s 
interest for the discovery and use of drugs with natural 
origin because of fewer side effects to treat these 
diseases, shallot plant can be more considered in this 
field. Of course, finding probable effective compound 
or compounds and their affecting mechanism in 
cardiovascular disease is an issue that its clarification 
requires further and more quantitative research.  
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